Structured page family:Cost guide

Teriparatide Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Teriparatide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Forteo pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Teriparatide varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)
~$3,500/month (Forteo); ~$4,200/month (Bonsity authorized generic)
Average wholesale price
~$3,200-$4,000/month
Pharmacy acquisition estimate
~$3,000-$3,800/month
Typical negotiated rate
~$2,200-$3,000/month
Price per dose
~$117 per 20 mcg dose
Annual cost at list price
~$42,000-$50,400

Pharmacy Price Comparison

PharmacyPrice RangeNotes
Specialty pharmacy$3,200-$4,200/monthRequired distribution channel
Bonsity (authorized generic)Slightly lower than ForteoSame active ingredient; may improve insurance coverage

Insurance Coverage Landscape

Commercial plans
~70-85% with documentation
Medicare Part D
Covered; may be in specialty tier
Medicaid
Most states cover with prior auth
VA coverage
On formulary for approved indications
TRICARE
Covered with prior auth
Employer plan typical tier
Tier 4-5 specialty; coinsurance 25-40% or high copay

Prior Authorization Guide

Required Documentation
  • DXA T-score ≤-2.5 with fracture history, or T-score ≤-3.0
  • Bisphosphonate failure or intolerance (often required)
  • Recent DXA report
  • Fracture documentation
Common Denial Reasons
  • No fracture history
  • Bisphosphonate not tried
  • T-score not severe enough
  • Plan requires endocrinologist prescription
Appeal Template Points
  • Severe osteoporosis with fracture
  • Bisphosphonate failure documented
  • High fracture risk (FRAX score)
  • Anabolic therapy clinically indicated
Expected timeline: 1-2 weeks

Savings Programs and Patient Assistance

Forteo Patient Assistance
manufacturer
Eligibility: Uninsured, ≤400% FPL
Savings: Free
Income limit: ≤400% FPL
Enrollment: moderate
Eli Lilly program
Savings card
copay
Eligibility: Commercially insured
Savings: May reduce copay significantly
Income limit: None
Enrollment: simple
Annual cap
Bonsity generic
pharmacy
Eligibility: All patients
Savings: Lower cost than Forteo
Income limit: None
Enrollment: simple
Authorized generic

Generic and Biosimilar Status

Generic available
Generic price range: ~10-20% below Forteo
Expected: Bonsity authorized generic available

Cost by Dose

Dose/RegimenMonthlyAnnual
20 mcg daily$3,500-$4,200$42,000-$50,400

Annual Cost Projection

Year 1
$0-$50,400 (2-year therapy limit)
Year 2
$0-$50,400
Year 3
$0 (therapy complete; transition to antiresorptive)
Assumptions
  • 2-year cumulative limit
  • Insurance/PAP reduces cost

Cost-Saving Strategies

  • 1.Use Bonsity authorized generic if available
  • 2.Apply for patient assistance if uninsured
  • 3.Ensure thorough prior auth documentation (DXA, fracture history, bisphosphonate failure)
  • 4.Work with specialty pharmacy for insurance appeals
  • 5.Plan for sequential antiresorptive therapy cost after month 24

International Price Comparison

CountryPrice RangeNotes
UK~£250-350/month (~$320-450)NHS
Canada~CAD $2,500-3,500 (~$1,900-2,600)Regulated

Need help comparing teriparatide paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a teriparatide provider
Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 2 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Teriparatide Cost FAQ

Sources

  1. 1. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    N Engl J Med • 2001
    Claim type: clinical
    View source →
  2. 2. FDA Information on Teriparatide
    FDA • 2026
    Claim type: regulatory
    View source →

This content is for informational purposes only and does not constitute medical advice.